Concepedia

Gerald A. Poore

GA

Statistics

Publications

20

Citations

2.1K

H-Index

16

Active since

1966

Affiliations

Eli Lilly (United States)(Current)

Duke Medical Center

University of California, Irvine

Duke University

University of California, Irvine Medical Center

Gerald A. Poore is an author at Eli Lilly (United States) specializing in pharmacology, cancer pharmacology, and medicine.

Publications per year

1966–1990

20

Publications

20

Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).

Larry W. Hertel, G B Boder, Julian S. Kroin et al. · PubMed · 1990 · 683 citations

, , +11

Alkaloids of Acronychia Baueri Schott I

Gordon H. Svoboda, Gerald A. Poore, Patrick J. Simpson et al. · Journal of Pharmaceutical Sciences · 1966 · 167 citations

, , +9

Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin.

Kenneth J. Widder, Robert Morris, Gerald A. Poore et al. · Proceedings of the National Academy of Sciences · 1981 · 162 citations · Full text

, , +14

Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: Total remission in Yoshida sarcoma-bearing rats

Kenneth J. Widder, Robert Morris, Gerald A. Poore et al. · European Journal of Cancer and Clinical Oncology · 1983 · 154 citations

, , +17

Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetyl vinblastine amide (vindesine) sulfate

Charles J. Barnett, George J. Cullinan, Koert Gerzon et al. · Journal of Medicinal Chemistry · 1978 · 138 citations

, , +8

1–5 of 20